Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

We’re guessing you picked two very different things. But try to imagine this: Somehow, both scenarios apply to Abbott’s FreeStyle Libre, which turned 10 years old in 2024. Right now, millions of ...

The complaint said that although Walgreens offered these lower prices to cash-paying customers, it charged more for the same drugs to customers using private insurance, Medicare or Medicaid.

Walgreen trademark fight can go to trial However, plaintiffs alleged the prices Walgreens charged to club members were “usual and customary” prices and that prices paid by insurers were higher ...

TD Cowen lowered the firm’s price target on Walgreens Boots Alliance (WBA) to $14 from $16 and keeps a Buy rating on the shares. The firm updated its estimates and based on its store closure ...

https://www.tipranks.com/news/the-fly/apellis-price-target-lowered-to-30-from-43-at-wells-fargo Jefferies analyst Brian Tanquilut lowered the firm’s price target on ...

Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Free Report)’s stock price rose 1.5% on Friday following a dividend announcement from the company. The company traded as high as $9.58 and last ...

The lawsuit alleged that the prices Walgreens charged to its savings club members were its “usual and customary” prices, and that the prices it reported to insurers for reimbursement were ...

Justin Sullivan / Getty Images Walgreens Boots Alliance stock moved lower following a price target cut by TD Cowen. Analysts also reduced their full-year profit forecasts, citing the impact of ...

Jefferies analyst Brian Tanquilut lowered the firm’s price target on Walgreens Boots Alliance (WBA) to $9 from $19 and keeps a Hold rating on the shares. While shares have moved higher following ...

The lawsuit alleged that the prices Walgreens charged to its savings club members were its “usual and customary” prices, and that the prices it reported to insurers for reimbursement were inflated. It ...

Walgreens has agreed to pay $100 million to settle a class action lawsuit accusing the pharmacy chain of inflating prescription drug prices for insured customers. The settlement, announced after ...